| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/30/2004 | EP1037880B1 Retinoic acid mimetic anilides |
| 06/30/2004 | EP1009743B1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation |
| 06/30/2004 | EP0996465B1 Compositions and articles for reducing the effects of inflammation |
| 06/30/2004 | EP0977560B1 IBUPROFEN THIOESTERS AS INHIBITORS OF Nf-kappaB-DEPENDENT PAIN AND INFLAMMATION MEDIATOR FORMATION |
| 06/30/2004 | EP0975596B1 Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors |
| 06/30/2004 | EP0971908B1 Il-8 receptor antagonists |
| 06/30/2004 | EP0862628B1 Receptor and nucleic acid molecule encoding said receptor |
| 06/30/2004 | CN1509462A Use of NF-kappa-B inhibitors in treatment of dry disorders |
| 06/30/2004 | CN1509335A Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles |
| 06/30/2004 | CN1509292A Combination apparoach to treatment of cancer using C-MYC antisense oligomer |
| 06/30/2004 | CN1509291A Oxazolo-and-furopyrimidines and their use in medicaments against tumors |
| 06/30/2004 | CN1509289A Imidazo[1,5,-A] pyrimido[5,4-d]benzazepine derivatives as GABAA receptor medulators |
| 06/30/2004 | CN1509286A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509282A 4-(phenyl-piperdin-4-ylidene-methyl)benzamide derivatives and theive use for treating pain, anxiety or gastrointestinal disorders |
| 06/30/2004 | CN1509281A Benzimidazol derivatives modulate che mokine receptors |
| 06/30/2004 | CN1509279A Process for production of citalopram |
| 06/30/2004 | CN1509278A N-phenyl-arylsulfonamide compound, drug comprising the compound as active ingredient, intermediate for the compound |
| 06/30/2004 | CN1509276A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509275A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509274A Metallo proteinase inhibitors |
| 06/30/2004 | CN1509273A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509272A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509271A 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for treatment of pain anxiety or gastrointestinal disorders |
| 06/30/2004 | CN1509270A Indolinons, substituted in position 6, and their preparation and use as kinase inhibitors |
| 06/30/2004 | CN1509269A 磺酰胺衍生物 Sulfonamide derivatives |
| 06/30/2004 | CN1509267A Thyroid hormone receptor atagonists for treating cardiac and metabolic disorders II |
| 06/30/2004 | CN1509196A 4(2-butylamino)-2,7-dimethyl-8-(2-methyl(-6-methoxyp-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine as corticotropin releasing factor receptor |
| 06/30/2004 | CN1509183A Use of proteasome inhibitors to treat dry eye disorders |
| 06/30/2004 | CN1509174A Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene |
| 06/30/2004 | CN1509173A Carboxylic and substituted oxazole derivatives for use as PPAR-& and PPAR-r activators in the treatment of diabetes |
| 06/30/2004 | CN1509172A Pirenzepine ophthalmic gel |
| 06/30/2004 | CN1509171A Use of pyrazoline derivatives in preparation of medicament for prevention and/or treatment of proliferative cell diseases |
| 06/30/2004 | CN1509170A Method for inhibiting adhesion formation |
| 06/30/2004 | CN1509168A Novel treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG |
| 06/30/2004 | CN1508137A 2-phenyl-substituted imidazo-triazone used as phosphodiesterase inhibitor |
| 06/30/2004 | CN1507903A Health-care product for antilipemic and preventing cardio-cerebrovascular disease |
| 06/30/2004 | CN1507895A Medicine for anti consumptive disease |
| 06/30/2004 | CN1507869A Combined preparation containing morpholine anthracyclines and anticancer agent |
| 06/30/2004 | CN1507851A Cosmetic containing purple bergenia herb element and method for extracting said element |
| 06/30/2004 | CN1155618C PEG-interferon conjugates |
| 06/30/2004 | CN1155612C Endothelin antagon |
| 06/30/2004 | CN1155608C Propargyl phenyl ether A2A receptor agonists |
| 06/30/2004 | CN1155597C Benzodioxan, benzofuran or benzopyranl derivatives having fundic relaxation properties |
| 06/30/2004 | CN1155594C Polymorphic salt as medicine for migraine |
| 06/30/2004 | CN1155589C Compounds and methods for modulation of estroglen receptors |
| 06/30/2004 | CN1155586C Substituted benzylthiazolidine-2,4-dione derivatives |
| 06/30/2004 | CN1155570C Novel cyano-indole serotonin reextracted inhibitor compound, its preparation process and medicinal compositions having same |
| 06/30/2004 | CN1155567C Antipsychotic indolyl derivatives |
| 06/30/2004 | CN1155562C New naphthalene compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/30/2004 | CN1155558C N-alkoxyalkyl-N, N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| 06/30/2004 | CN1155409C Medical compsns. for preventing and treating arteriosclerotic desease |
| 06/30/2004 | CN1155406C Nitrogen oxide generation inhibitor |
| 06/30/2004 | CN1155402C Compounds that inhibit interaction between signal-transducing proteins and GLGF(PDZ/DHR) domain and uses thereof |
| 06/30/2004 | CN1155395C Process for preparing roaster colostrum from pig's antibody serum |
| 06/30/2004 | CN1155385C Formulation comprising testosteron undecanoate and castor oil |
| 06/30/2004 | CN1155381C New pharmaceutical use of sinomenine |
| 06/30/2004 | CN1155377C Anti-first-pass effect compounds |
| 06/30/2004 | CN1155374C Novel biological activity of proglumide |
| 06/29/2004 | US6756511 Treating alzheimer's disease by preventing formation of insoluble amyloid beta and arresting its production |
| 06/29/2004 | US6756481 IL-23 receptor binding compositions |
| 06/29/2004 | US6756401 Drug mixtures comprising estrogen agonists or antagonists and anticholesterol statins, administered to promote bone formation, prevent bone disorders and/or as anticholesterol agents |
| 06/29/2004 | US6756398 Positive modulators of nicotinic receptor agonists |
| 06/29/2004 | US6756397 Such as (s)-n-(2-((1-chloromethyl)-1,2-dihydro-5-((4-methylpiperazino)carbonyloxy) -3h-benz(e) indol-3-yl)carbonyl)-1h-indol-5-yl)-5-((3-methyldithio-1-oxopropyl)-amino) -1h-indole-2-carboxamide; enhanced water solubility and stability |
| 06/29/2004 | US6756395 Cyclization of n-(4-cyanomethylphenyl)methanesulfonamides with ethylenediamine to form n-(4-imidazol-2-ylmethyl)-phenyl) -methanesulfonamides; incontinence, sexual dysfunction, nasal congestion, and cns disorders; alpha 1 adrenergic agonists |
| 06/29/2004 | US6756393 Amides and ureas n-substituted with piperidine or nortropane; serotonin inverse agonists or antagonists; antipsychotic |
| 06/29/2004 | US6756388 Having piperidinyl and phenolic functionality; bone loss; breast or prostate cancer |
| 06/29/2004 | US6756383 Such as 3-(2-(methoxycarbonyl)acetylamino)pyridine-4-carboxylic acid for treatment of diseases characterized by activity of vascular endothelial growth factor receptor tyrosine kinases; enzyme inhibitors |
| 06/29/2004 | US6756382 Amide substituted imidazoquinolines |
| 06/29/2004 | US6756381 A purified antitumor agent is crystallized from acetone or dichloromethane |
| 06/29/2004 | US6756380 5-phenyl-pyrimidine derivatives |
| 06/29/2004 | US6756376 Preventing fatty acid release |
| 06/29/2004 | US6756371 Morpholino or thiomorpholino derivatives; respiratory system disorders |
| 06/29/2004 | US6756370 Piperidine alcohols |
| 06/29/2004 | US6756362 Anionic polymers including dermatan sulfate, chondroitin sulfate, keratan sulfate, heparan sulfate, heparin, dextran sulfate, pentosan polysulfate, hyaluronic acid and alginate. |
| 06/29/2004 | US6756359 Administering a 14 membered macrolide and ketolide antibiotics containing c12 modifications to a patient suffering from bacterial infections |
| 06/29/2004 | US6756213 Nucleic acid encoding retinoic acid receptor |
| 06/29/2004 | US6756206 Adsorption and removal of endotoxin from physiological fluids using cationic helix peptides |
| 06/29/2004 | US6756047 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/29/2004 | US6756045 Topically applied idebenone-containing agent with protective and regenerative effect |
| 06/29/2004 | US6756042 Salmonella vaccine; immunogenicity; reduced possibility of strain revertion to reactive form; safe; limited side effects |
| 06/29/2004 | CA2296726C Combination therapy |
| 06/29/2004 | CA2294476C Semaphorin receptors |
| 06/29/2004 | CA2290017C Method for producing orally administered, solid pharmaceutical products with controlled release of the active substance |
| 06/29/2004 | CA2263913C Substituted 6,6-hetero-bicyclic derivatives |
| 06/29/2004 | CA2207404C Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase |
| 06/29/2004 | CA2205384C Dihydropyrimidines and uses thereof |
| 06/29/2004 | CA2171827C Use of thiazolidinediones to prevent or delay onset of niddm |
| 06/24/2004 | WO2004053124A1 Method of screening remedy or preventive for diabetes |
| 06/24/2004 | WO2004052886A1 Indol derivatives and their use as 5-ht ligands |
| 06/24/2004 | WO2004052863A1 Anti-inflammatory agent |
| 06/24/2004 | WO2004052862A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 06/24/2004 | WO2004052859A1 Erythropoietin production accelerator |
| 06/24/2004 | WO2004052855A2 Substituted 3-carbonyl-1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/24/2004 | WO2004052853A2 Substituted 3-alkyl and 3-arylalkyl 1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/24/2004 | WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators |
| 06/24/2004 | WO2004052399A1 Composition for topical anesthesia |
| 06/24/2004 | WO2004052385A1 Composition containing green and yellow vegetables and light-colored vegetables |
| 06/24/2004 | WO2004052379A1 Antidiarrheal composition |
| 06/24/2004 | WO2004052365A2 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
| 06/24/2004 | WO2004024883A3 PAKs AS MODIFIERS OF THE CHK PATHWAY AND METHODS OF USE |